Global Femoral Cannula Market Growth 2025-2031

Global Femoral Cannula Market Growth 2025-2031

The global Femoral Cannula market size is predicted to grow from US$ 38.2 million in 2025 to US$ 53.9 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.

Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.

Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.

The main producers are mainly in Europe and the United States.

LP Information, Inc. (LPI) ' newest research report, the “Femoral Cannula Industry Forecast” looks at past sales and reviews total world Femoral Cannula sales in 2024, providing a comprehensive analysis by region and market sector of projected Femoral Cannula sales for 2025 through 2031. With Femoral Cannula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Femoral Cannula industry.

This Insight Report provides a comprehensive analysis of the global Femoral Cannula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Femoral Cannula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Femoral Cannula market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Femoral Cannula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Femoral Cannula.

This report presents a comprehensive overview, market shares, and growth opportunities of Femoral Cannula market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Unipolar
Bipolar

Segmentation by Application:
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG

Key Questions Addressed in this Report

What is the 10-year outlook for the global Femoral Cannula market?

What factors are driving Femoral Cannula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Femoral Cannula market opportunities vary by end market size?

How does Femoral Cannula break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.